What will remove the fetter off of MNTA? The most likely thing will be copaxone approval. Until Teva's credibility on the Street is dissolved, it is mCopaxone that will be the next major catalyst for the stock. Said decision should come before the tLovenox issue wears down as a fetter.
In that regard, it is up to the FDA how they want to handle it, but I am confident that MNTA has characterized and reversed engineered mCopaxone just as they did mLovenox. mLovenox may be screwed up stock wise because of the contract, but mCopaxone has the appropriate contract in place.
This will give MNTA even more credibility on the Street once the FOB candidates start rolling out. The Street will have to give credit for mCopaxone earnings, and give real credibility to the fact that MNTA may very well bring FOBs to market. Therefore, mLovenox, in the long run, will fall back as a cash cow but not the driver of the stock that it initially was.
Then again, if 2011 passes and no tLovenox and no aLovenox, some eyes may open up as well.
Tinker
